Thrombotic complications of central venous catheterization with peripherally inserted catheters in patients with classical‐Hodgkin lymphoma

Documenti analoghi

• Predicting thrombotic risk in patients with classical Hodgkin lymphoma: Thro‐HL multicenter study
  di: Giovanni Manfredi Assanto, et al.
  Pubblicazione: (2025)
• Optimizing therapy for relapsed/refractory classic Hodgkin lymphoma in the era of PD‐1 blockade
  di: Thomas M. Kuczmarski, et al.
  Pubblicazione: (2025)
• Characterization of cancer‐associated fibroblasts and their spatial architecture reveals heterogeneity and survival associations in classic Hodgkin lymphoma
  di: Suvi‐Katri Leivonen, et al.
  Pubblicazione: (2025)
• Human leukocyte antigen (HLA) class I expression on Hodgkin–Reed–Sternberg cells is an EBV‐independent major determinant of microenvironment composition in classic Hodgkin lymphoma
  di: Berit Müller‐Meinhard, et al.
  Pubblicazione: (2024)
• Correction to “Single‐cell RNA sequencing of pediatric Hodgkin lymphoma to study the inhibition of T cell subtypes”
  Pubblicazione: (2024)